Trial site
Foshan First People's Hospital
- 11running trials
- 4closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Liver and biliary tract cancer2 trials
- Acute myeloid leukaemia1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Hepatitis B1 trial
- Multiple myeloma1 trial
- Stroke1 trial
- Thalassaemia1 trial
- Phase
- Phase 27 trials
- Phase 33 trials
- Early phase 11 trial
- Status
- Not yet recruiting6 trials
- Completed4 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.2 trials
- Alpha Biopharma (Jiangsu) Co., Ltd.1 trial
- Bayer1 trial
- Beijing 302 Hospital1 trial
- Beijing InnoCare Pharma Tech Co., Ltd.1 trial
- and 9 more
Running trials
Not yet recruiting
A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT)
Recruiting
JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma
Recruiting
Not yet recruiting
A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
Not yet recruiting
Recruiting
Recruiting
A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality
Recruiting
Not yet recruiting
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
Active, not recruiting
Active, not recruiting
A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Acute myeloid leukaemia1 recruiting
- Coronary artery disease1 recruiting
- Hepatitis B1 recruiting
- Liver and biliary tract cancer1 recruiting
- Multiple myeloma1 recruiting
- Thalassaemia1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026